H.L. HEALTHCARE PVT LTD

ACCOUNTS HEAD: MARG Software & Pharma experienced able to handle GST, ESI, PF. Job Types: Full-time, Permanent Pay: ₹20,000.00 - ₹60,000.00 per month Benefits: Cell phone reimbursement Internet reimbursement Leave encashment Life insurance Paid sick time Paid time off Schedule: Day shift Supplemental Pay: Joining bonus Overtime pay Performance bonus Shift allowance Ability to commute/relocate: Chandigarh, Chandigarh: Reliably commute or planning to relocate before starting work (Preferred) Education: Bachelor's (Preferred) Experience: Account management: 5 years (Required) Work Location: In person Application Deadline: 24/06/2025 Expected Start Date: 01/07/2025

PHARMA SALES, 5-8 YEAR EXPERENCE IN THIRD PARTY MFG OF TAB CAP AND LIQUID SECTIONS, ABLE TO GENERATE THIRD PARTY ORDERS & ARRANGE INSTITUTIONAL SALES Job Types: Full-time, Permanent Pay: ₹30,000.00 - ₹75,000.00 per month Benefits: Cell phone reimbursement Internet reimbursement Leave encashment Life insurance Paid sick time Paid time off Work from home Schedule: Day shift Supplemental Pay: Performance bonus Yearly bonus Language: English (Required) Work Location: In person Application Deadline: 27/06/2025 Expected Start Date: 01/07/2025

You should have a minimum of 5-8 years of experience in third party manufacturing of tablet, capsule, and liquid sections in the pharmaceutical sales industry. Your primary responsibilities will include generating third party orders and arranging institutional sales. This is a full-time, permanent position with benefits such as cell phone and internet reimbursement, leave encashment, life insurance, paid sick time, paid time off, and the option to work from home. You will be working day shifts and may be eligible for performance bonuses and yearly bonuses based on your performance. Proficiency in English is required for this role, and you will be expected to work in person at the designated work location. The application deadline for this position is June 27, 2025, and the expected start date is July 1, 2025.,